Status:

COMPLETED

Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

Lead Sponsor:

Indiana University

Conditions:

Cholestasis of Parenteral Nutrition

Eligibility:

All Genders

Phase:

PHASE3

Brief Summary

Intestinal failure associated liver disease is a cholestatic liver disease associated with prolonged need for parenteral nutrition that can lead to such significant complications as liver failure. In ...

Detailed Description

Intestinal failure associated liver disease (IFALD) is a cholestatic liver disease associated with prolonged need for parenteral nutrition. This disease can lead to such serious complications as liver...

Eligibility Criteria

Inclusion

  • Neonates with anticipated need for parenteral nutrition (based on primary physicians opinion) for greater than or equal to four weeks and one of the following diagnoses:
  • Anatomic: Neonate with intestinal atresia, omphalocele, gastroschisis, or volvulus with or without intestinal resection.
  • Ischemic/perforation: Neonates with spontaneous intestinal perforation or necrotizing enterocolitis requiring surgical intervention.

Exclusion

  • Current weight less than 750 grams
  • AST or ALT greater than 5 times the upper limit of normal within 2 weeks of enrollment
  • Direct bilirubin greater than 2 mg/dL on any consecutive measurements 5 - 7 days apart within 2 weeks of enrollment
  • Severe coagulopathy with INR greater than 95th percentile for age (\>1.7 at less than 5 days of age, \> 1.5 older than five days of age)
  • Culture confirmed sepsis with positive blood, urine, or CSF culture within 2 weeks of enrollment
  • Renal failure requiring dialysis
  • Cyanotic heart disease requiring prostaglandin therapy
  • Hypertriglyceridemia (greater than 250mg/dL) at time of enrollment

Key Trial Info

Start Date :

November 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 19 2024

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT03387579

Start Date

November 30 2018

End Date

March 19 2024

Last Update

July 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Riley Hospital for Children at IU Health

Indianapolis, Indiana, United States, 46202